XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Equity Based Compensation
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Equity Based Compensation
Equity Based Compensation
Equity compensation expense was $35 million and $31 million for the nine months ended September 30, 2023 and 2022, respectively. In the first quarter of 2023, the Company granted 129,146 stock appreciation rights at $138.34 weighted average exercise price per share, 185,311 performance contingent shares and 105,122 restricted stock units to employees. As of September 30, 2023, 1,638,062 share awards at a weighted average strike price per share of $114.32 were vested and exercisable with a remaining weighted average exercise period of 4.1 years. As of September 30, 2023, the total compensation cost of non-vested awards not yet recognized in the financial statements was $37 million. It is estimated that these costs will vest over a weighted average period of 0.7 years.